Overview
Hisayuki Yokoyama practices in Yamagata, Japan. Yokoyama is highly rated in 5 conditions, according to our data. Their top areas of expertise are Leukemia, Acute Myeloid Leukemia (AML), Graft Versus Host Disease (GvHD), Bone Marrow Transplant, and Bone Marrow Aspiration.
Their clinical research consists of co-authoring 118 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Myeloid Leukemia (AML)Yokoyama isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- Cytomegalovirus InfectionYokoyama isAdvanced. Learn about Cytomegalovirus Infection.
- Graft Versus Host Disease (GvHD)
- LeukemiaYokoyama isAdvanced. Learn about Leukemia.
- Sideroblastic AnemiaYokoyama isAdvanced. Learn about Sideroblastic Anemia.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Yokoyama isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Megakaryoblastic LeukemiaYokoyama isExperienced. Learn about Acute Megakaryoblastic Leukemia.
- Adult Immune ThrombocytopeniaYokoyama isExperienced. Learn about Adult Immune Thrombocytopenia.
- Adult T-Cell LeukemiaYokoyama isExperienced. Learn about Adult T-Cell Leukemia.
- AgranulocytosisYokoyama isExperienced. Learn about Agranulocytosis.
- Anaplastic Large Cell LymphomaYokoyama isExperienced. Learn about Anaplastic Large Cell Lymphoma.